June 2022 | AIChE

You are here

June 2022

Gaetan Burgio

Gaetan Burgio, MD, PhD is leading a research laboratory at the John Curtin School of Medical Research, the Australian National University, Australia. Gaetan completed a medical degree at Paris and then completed a PhD in mammalian genetics at the Pasteur Institute (Paris) and the National Museum of Natural History (Paris). He migrated to Australia in 2008 Joined Prof Simon Foote’s laboratory as a postdoctoral fellow. In 2015 Gaetan established his laboratory at the Australian National University at Canberra, Australia. 

Gaetan’s research aims to gain a fundamental understanding...Read more

Vivek Mutalik

Dr. Mutalik is a Staff Scientist and Principal Investigator at the Environmental Genomics and Systems Biology Division, Functional genomics Department, and Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA. His research group is focused on developing tools and technologies to study and engineer diverse bacteria, phages and their interactions. He won R & D 100 award for a high-throughout functional genomics technology. Dr. Mutalik is passionate about establishing Phage Foundry, a unified facility for engineering phages and phage-like...Read more

Thomas Gaj

Thomas Gaj is an assistant professor of bioengineering at the University of Illinois Urbana-Champaign, where he is also a member of the Carl R. Woese Institute for Genomic Biology. He received his Ph.D. in chemistry from the Scripps Research Institute in La Jolla, CA, and completed his postdoctoral training at the University of California, Berkeley. His research group is focused on the application of DNA and RNA editing technologies to treat neurodegenerative conditions.Read more

Fyodor Urnov

Fyodor Urnov is a Professor of Molecular Therapeutics at UC Berkeley and a Scientific Director at its Innovative Genomics Institute. He co-developed the toolbox of human genome and epigenome editing and led the team that developed a strategy for genome editing in the hemoglobinopathies, sickle cell disease and beta-thalassemia, that has yielded sustained clinical benefit for subjects in several ongoing clinical trials. At the IGI Fyodor directs efforts to develop scalable CRISPR-based approaches to treat diseases of the immune system, sickle cell disease, neurodegeneration, and...Read more

David Taylor

David Taylor is an Associate Professor and an American Cancer Society Research Scholar in the Department of Molecular Biosciences at the University of Texas at Austin. There, he is the Director of the Sauer Structural Biology Laboratory and a member the Center for Systems and Synthetic Biology and the LIVESTRONG Cancer Institutes at Dell Medical School. David received his B.S. in Biochemistry summa cum laude from Syracuse University in 2008. He completed his Ph.D. with distinction in Molecular Biophysics and Biochemistry at Yale University in 2013. In 2014, he joined the laboratories of...Read more

5th Food Innovation and Engineering (FOODIE) Conference

December 5, 2022 to December 6, 2022
The FOODIE Conference will discuss emerging technologies for food production, analyze strategies to connect industry and cuisine, and navigate methods to fit the consumer market. Stay up to date on the latest in cutting-edge advancements involving nutrition products, sustainability within the food...

Asma Hatoum-Aslan

Dr. Hatoum-Aslan is an Assistant Professor of Microbiology at the University of Illinois at Urbana-Champaign (UIUC). She received her B.Sc. in Molecular Biology from Florida Tech,  M.Sc. in Biochemistry from the American University of Beirut, and her Ph.D. in Biochemistry from Cornell University in 2007. Subsequently, she completed postdoctoral training at the Rockefeller University in the Laboratory of Bacteriology. She started her independent research program at the University of Alabama in 2014 and moved to UIUC in 2020.

Her research aims to advance the basic knowledge of...Read more

Kyle Watters

Kyle Watters leads the Orchard discovery team at Arbor Biotechnologies in Cambridge MA, with the goal of finding and building new genetic engineering tools sourced from metagenomic data. He earned his PhD from Cornell University in 2016, studying the relationship between the structure and function of RNAs using high-throughput chemical probing for synthetic biology applications. After finishing his PhD, Kyle discovered new anti-CRISPR proteins at the University of California Berkeley as a postdoc in the lab of Jennifer Doudna. He has been at Arbor since 2018.Read more

Lucas Harrington

As co-founder and CSO of Mammoth Biosciences, Lucas drives the translation of novel CRISPR platforms for therapeutics. Mammoth Biosciences was founded with the goal of harnessing the diversity of life to power permanent cures for genetic diseases and to democratize disease detection. Lucas conducted his undergraduate work in chemistry at Washington University in St. Louis and Ph.D. at the University of California, Berkeley in the laboratory of Jennifer Doudna. Lucas is also a general partner for SciFounders Capital, a fund and incubator with the goal of helping more scientists start and...Read more

Pages